NASDAQ:VRAX

Virax Biolabs Group Stock Forecast

etoro logo Buy VRAX
*Your capital is at risk
$3.26
+0.150 (+4.82%)
At Close: Jun 29, 2026
AI Analysis AI Analysis of VRAX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add VRAX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Virax Biolabs Group Limited stock price on Monday moving 17.52% between high and low
(Updated on Jun 29, 2026)

Sell candidate since Jun 10, 2026 Loss -26.33%

The Virax Biolabs Group Limited stock price gained 4.82% on the last trading day (Monday, 29th Jun 2026), rising from $3.11 to $3.26. During the last trading day the stock fluctuated 17.52% from a day low at $3.14 to a day high of $3.69. The price has fallen in 6 of the last 10 days and is down by -29.13% for this period. Volume fell on the last day by -273 thousand shares and in total, 403 thousand shares were bought and sold for approximately $1.31 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.12 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 11.60% during the next 3 months and, with a 90% probability hold a price between $3.49 and $9.31 at the end of this 3-month period.

VRAX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 4.82%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Virax Biolabs Group Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.62 and $4.78. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Virax Biolabs Group Limited stock

Virax Biolabs Group Limited finds support from accumulated volume at $3.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.550 between high and low, or 17.52%. For the last week the stock has had daily average volatility of 25.20%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VRAX) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect Virax Biolabs Group Limited to open at $3.36, and during the day (based on 14 day Average True Range), to move between $2.84 and $3.68, which gives a possible trading interval of +/-$0.85 (+/-29.87%) up or down from last closing price. If Virax Biolabs Group Limited takes out the full calculated possible swing range there will be an estimated 29.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.15 (3.37%) than the resistance at $3.70 (13.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Virax Biolabs Group Limited stock A Buy?

The Virax Biolabs Group Limited stock holds several negative signals and despite the positive trend, we believe Virax Biolabs Group Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.184 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 30, 2026 - $3.36 ( 3.17%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

VRAX Performance

Trading levels for VRAX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.91 20.04%
R2 3.70 13.60%
R1 3.57 9.61%
Price 3.26
S1 3.15 -3.28%
S2 3.02 -7.26%
S3 2.81 -13.70%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.75 15.03%
R2 3.73 14.34%
R1 3.70 13.50%
Price 3.26
S1 3.15 -3.37%
S2 3.11 -4.60%
S3 2.60 -20.17%

FAQ

What is the symbol for Virax Biolabs Group Limited Stock and on which exchange is it traded?
The symbol for Virax Biolabs Group Limited is VRAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Virax Biolabs Group Limited Stock?
The Virax Biolabs Group Limited stock holds several negative signals and despite the positive trend, we believe Virax Biolabs Group Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Virax Biolabs Group Limited Stock?
Virax Biolabs Group Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Virax Biolabs Group Limited Stock.

What's the current price of Virax Biolabs Group Limited Stock?
As of the end of day on the Jun 29, 2026, the price of an Virax Biolabs Group Limited (VRAX) share was $3.26.

What is the 52-week high and low for Virax Biolabs Group Limited Stock?
The 52-week high for Virax Biolabs Group Limited Stock is $28.50 and the 52-week low is $2.50.

What is the market capitalization of Virax Biolabs Group Limited Stock?
As of the Jun 29, 2026, the market capitalization of Virax Biolabs Group Limited is 608.398K.

When is the next earnings date for Virax Biolabs Group Limited?
The upcoming earnings date for Virax Biolabs Group Limited is Dec 02, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IIIV
$20.09
5.03% Jun 25
X
XMAX
$8.34
7.31% Jun 24
NMRK
$15.02
1.60% Jun 24
JLL
$299.78
4.44% Jun 24
CAG
$13.43
4.06% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE